Selected Grants
An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus (ADDRESS+)
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2021 - 2025A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers Cost Reimbursable
Clinical TrialCollaborator · Awarded by Food and Drug Administration · 2021 - 2024A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus)
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2021 - 2024Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker
ResearchPrincipal Investigator · Awarded by MicroElastic Ultrasound Systems, Inc. · 2019 - 2022Keratinocyte targeted strategies for treatment of cutaneous GVHD
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2021An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus (ADDRESS+)
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2021 - 2025A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers Cost Reimbursable
Clinical TrialCollaborator · Awarded by Food and Drug Administration · 2021 - 2024A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus)
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2021 - 2024Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker
ResearchPrincipal Investigator · Awarded by MicroElastic Ultrasound Systems, Inc. · 2019 - 2022Keratinocyte targeted strategies for treatment of cutaneous GVHD
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2021Effect of Dupilumab (anti-IL4R¿) on the Host-Microbe Interface in Atopic Dermatitis ATOPIC DERMATITIS RESEARCH NETWORK (ADRN)
Clinical TrialPrincipal Investigator · Awarded by National Jewish Health · 2018 - 2021Pilot Study Evaluating the Efficacy of a Topical PDE-4 Inhibitor for Morphea
Clinical TrialPrincipal Investigator · Awarded by Pfizer, Inc. · 2017 - 2020Quantitative Assessment of Disease Severity in Chronic Cutaneous Graft vs Host Disease
FellowshipPrincipal Investigator · Awarded by Dermatology Foundation · 2012 - 2015External Relationships
- MicroElastic Ultrasound Systems Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.